Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2013-05-15 15:53:48 |
Versijas komentārs | |
Teksts |
Olainfarm will
Hold Investor Conference Webinar about Recent Developments
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its investor conference webinar
scheduled on May 15, 2013 at 16:00 (EET).
Webinar will be
hosted by the member of the management board Salvis Lapiņš. The
presentation will be in English. During the webinar
topics in relation to AS “Olainfarm” expansion plans and analysis
of company’s recent activities and financial results will be
discussed. How to join the
webinar?
type in your name, surname and
click „enter”. You will be then directed to the webinar screen.
Prior registration is not necessary. During the webinar
the enclosed presentation was presented. A/s OlainFarm is one of the biggest pharmaceutical companies in Latvia with 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 30 countries of the world, including the
Baltics, Russia, other CIS, Europe, Asia, North America and
Australia.
Information prepared by:
e-mail:
Salvis.Lapins@OlainFarm.lv |
Pielikumi |